HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
MGTX
MeiraGTx Holdings plc
There isn't enough reported data to score MGTX yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
MGTX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Under pressure | |
| Strong |
MGTX's profitability and balance sheet are currently strong, but its cash flow is under pressure. There isn't enough data to rate its revenue.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
MGTX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 11x | $8.79 | — |
| Cheap | 13x | $10.39 | +18% |
| Fair | 15x | $12.22 | +39% |
| Expensive | 19x | $15.50 | +76% |
Historical ranges are pointers, not guarantees.
MGTX's PE is 11x, but its earnings don't support one, so it isn't a reliable read right now.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
MGTX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect MGTX's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
MGTX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.80 | +$2.90 |
| Q2 2026 | $0.71 | +$2.74 |
| Q1 2026 | -$1.48 | +$0.83 |
| Q4 2025 | -$1.42 | +$0.70 |
| Q3 2025 | -$2.10 | -$0.87 |
| Q2 2025 | -$2.03 | -$0.61 |
| Q1 2025 | -$2.31 | -$1.12 |
| Q4 2024 | -$2.12 | -$0.63 |
MGTX has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over MGTX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over MGTX on profitability, with a higher operating margin.
MGTX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.8M | +1074% |
| Q2 2026 | $321.4M | +8609% |
| Q4 2025 | $75.4M | +252% |
| Q3 2025 | $410K | -96% |
| Q2 2025 | $3.7M | +1209% |
| Q3 2024 | $10.9M | +114% |
| Q2 2024 | $282K | -92% |
| Q1 2024 | $697K | -79% |
MGTX's revenue is growing: $5M last quarter, up 1074% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1036% | +10196 points |
| Q2 2026 | 76% | +1290 points |
| Q1 2026 | -13931% | N/A |
| Q4 2025 | 35% | +182 points |
| Q3 2025 | -11232% | -10865 points |
| Q2 2025 | -1214% | +15066 points |
| Q4 2024 | -147% | N/A |
| Q3 2024 | -367% | +275 points |
MGTX's operating margin was −1036% last quarter, up 10196 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over MGTX on cash generation, producing positive trailing cash flow while its opponent burns cash.
MGTX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$26.3M | -$13.5M |
| Q2 2026 | -$38.9M | +$6.3M |
| Q1 2026 | $15.8M | +$54.3M |
| Q4 2025 | $46.4M | +$70.9M |
| Q3 2025 | -$12.8M | +$12.9M |
| Q2 2025 | -$45.2M | -$24.4M |
| Q1 2025 | -$38.5M | -$119K |
| Q4 2024 | -$24.5M | -$6.9M |
MGTX has burned cash in almost every quarter: −$3M over the past year, against −$121M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over MGTX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
MGTX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +3.1M shares |
| 1 year | +20% | +15.9M shares |
| 3 years | +63% | +37.4M shares |
| 5 years | +119% | +52.7M shares |
| Available history | +192% | +63.7M shares |
MGTX has 97M diluted shares, up 20% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $18.2M |
| Q4 2022 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
MGTX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
MGTX has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
MGTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 6.8 | Oversold |
MGTX's weekly RSI is 38 (neutral) and its Stochastic is 7 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
MGTX PE vs Healthcare Sector
| Metric | MGTX | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 26x | 57% below |
MGTX is trading at 11x earnings, a 57% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
MGTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.77 | 10% below |
| 20 week MA | $11.8 | 26% below |
| 50 week MA | $9.90 | 11% below |
| 100 week MA | $8.49 | 3.5% above |
| 200 week MA | $7.11 | 24% above |
MGTX has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
MGTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.1 | $16.4 | -18% |
| 2021 | $16.4 | $22.4 | +36% |
| 2022 | $22.4 | $6.01 | -73% |
| 2023 | $6.01 | $7.02 | +17% |
| 2024 | $7.02 | $6.21 | -12% |
| 2025 | $6.21 | $7.97 | +28% |
| 2026 YTD | $7.97 | $8.79 | +10% |
MGTX has the edge over HIMS on returns for 2026, with the stronger performance.